Treatment of older adults with peripheral T cell lymphoma (PTCL) amidst a changing therapeutic landscape: a 20-year single institution experience.
0/5 보강
APA
Faisal MS, Anampa Guzman A, et al. (2026). Treatment of older adults with peripheral T cell lymphoma (PTCL) amidst a changing therapeutic landscape: a 20-year single institution experience.. Leukemia & lymphoma, 67(4), 947-951. https://doi.org/10.1080/10428194.2025.2589932
MLA
Faisal MS, et al.. "Treatment of older adults with peripheral T cell lymphoma (PTCL) amidst a changing therapeutic landscape: a 20-year single institution experience.." Leukemia & lymphoma, vol. 67, no. 4, 2026, pp. 947-951.
PMID
41348094 ↗
같은 제1저자의 인용 많은 논문 (3)
- Pregnancy-Related Adverse Events with Tyrosine Kinase Inhibitor Use in Chronic Myeloid Leukemia: A FAERS Pharmacovigilance Analysis (2001-2024).
- Irinotecan dosing and pharmacogenomics: a comprehensive exploration based on variants and emerging insights.
- Malignancy risk in individuals with familial adenomatous polyposis receiving biologics and immunomodulators.